Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

102.11
Delayed Data
As of Jun 24
 -3.17 / -3.01%
Today’s Change
101.03
Today|||52-Week Range
185.92
-34.80%
Year-to-Date
Gurus Invest in Top Biotechnology Stocks
Jun 20 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close105.28
Today’s open101.11
Day’s range101.10 - 104.93
Volume1,343,029
Average volume (3 months)731,329
Market cap$4.5B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+8.87%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+13.76%
P/E ratio5.8
Price/Sales5.47
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...0.000.00%
GRFSGrifols SA-0.58-3.61%
ACADACADIA Pharmaceutica...-2.07-6.18%
NBIXNeurocrine Bioscienc...-1.31-2.94%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$3.10
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Co-Chief Executive Officer
Martine A. Rothblatt
President, Co-Chief Executive Officer &
Director
Roger A. Jeffs
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers

Search for Jobs